Reckitt Benckiser Group plc (GB00B24CGK77) traded at $13.96 in OTC quote data on August 21, 2026, with a $41.914 billion market cap and a 52-week range of $58.67 to $90.71 on the same quote page.<\/p>\n
The latest visible company event is the expiration and results of a tender offer and consent solicitation for Mead Johnson Nutrition Company notes due 2044, a debt-management move that followed the company’s H1 2026 earnings season and pricing actions.<\/p>\n
Debt cleanup stays in view<\/p>\n
The most recent market snapshot also shows a $0.06 decline, or 0.43%, from the prior close, with only 350 shares changing hands in the delayed OTC line. That leaves the stock near a low-volume session while investors weigh a $10.11 trailing P\/E and a $6.53 trailing EPS.<\/p>\n
On the operating side, the same quote page puts trailing revenue at $14.2 billion and trailing net income at $3.2 billion. That combination implies a 22.40% profit margin, a level that looks stronger than many consumer-staples peers in a higher-cost backdrop.<\/p>\n
Cash and valuation<\/p>\n
Reckitt’s balance-sheet snapshot shows $1.95 billion in cash, $3.0 billion in levered free cash flow, and debt-to-equity of 109.56%. The market is therefore still pricing the group as a cash-generative defensive name rather than a pure growth story.<\/p>\n
A Bloomberg report on August 20, 2026 said European shares were flat as oil and inflation concerns offset a bond recovery, a backdrop that matters for household-goods names with pricing power. For Reckitt, the more relevant comparison is that its 2026 market cap and profitability metrics remain anchored by a relatively modest leverage profile and a 4.41% forward dividend yield on the quote page.<\/p>\n
Dettol and Durex<\/p>\n
Reckitt’s portfolio spans Dettol, Durex, Gaviscon, Nurofen, Strepsils, and Enfamil, with each brand aimed at a different corner of health, hygiene, and infant nutrition. That mix is central to the group’s defensive pitch because it blends everyday consumer demand with products that carry more resilient pricing.<\/p>\n
The July 27, 2026 quote snapshot on Yahoo Finance lists an OTCQX delayed price of $66.00 for RBGPF and a market cap of $41.914 billion, while the August 21, 2026 market view shows $13.96 for RBGLY on OTC Markets with the same company identity. As of August 21, 2026, the latest quoted U.S. line remains the $13.96 level.<\/p>\n
Fact box<\/p>\n
Company: Reckitt Benckiser Group plc
ISIN: GB00B24CGK77
Ticker: RBGLY
Exchange: OTCQX
Price (as of August 21, 2026, 3:24 p.m. ET): $13.96 USD
Market cap: $41.914 billion (as of August 21, 2026)
Sector \/ Industry: Consumer Defensive \/ Household & Personal Products
Index membership: FTSE 100<\/p>\n
More on Reckitt Benckiser stock<\/p>\n
Reckitt Benckiser stock is backed by a $41.914 billion market cap, a 52-week range of $58.67 to $90.71, and trailing revenue of $14.2 billion. The share line at $13.96 was unchanged in the quoted session aside from a $0.06 daily move.<\/p>\n
\n\t\t Disclaimer…
\n\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"Reckitt Benckiser Group plc (GB00B24CGK77) traded at $13.96 in OTC quote data on August 21, 2026, with a…\n","protected":false},"author":2,"featured_media":107980,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[21355],"tags":[21377,21376],"class_list":["post-107979","post","type-post","status-publish","format-standard","has-post-thumbnail","category-reckitt-benckiser","tag-gb00b24cgk77","tag-reckitt-benckiser"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/117132216741401992","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/107979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=107979"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/107979\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/107980"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=107979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=107979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=107979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}